Evidence-based guideline: Premature Ovarian Insufficiency † ‡
ESHRE A, Yeganeh L, Giri R, Flanagan M, Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, Gravholt C, Kalantaridou S, Kallen A, Kim K, Misrahi M, Mousa A, Nappi R, Rocca W, Ruan X, Teede H, Vermeulen N, Vogt E, Vincent A. Evidence-based guideline: Premature Ovarian Insufficiency † ‡. Fertility And Sterility 2024 PMID: 39652037, DOI: 10.1016/j.fertnstert.2024.11.007.Peer-Reviewed Original ResearchHealth care professionalsCentre for Research ExcellencePremature ovarian insufficiencyProvision of careGuideline development groupCare professionalsRandomised controlled trialsDiagnosis of premature ovarian insufficiencyAnti-Mullerian hormoneBritish Menopause SocietyData Safety Monitoring BoardHormone therapyInternational Menopause SocietyBayer PharmaScoping surveyAmerican Society for Reproductive MedicineWomen's healthConsulting feesMenopause SocietyReproductive Scientist Development ProgramAdvisory boardOvarian insufficiencyAttending meetingsClinical questionsSurvey of womenEvidence-based guideline: premature ovarian insufficiency,
Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, Gravholt C, Kalantaridou S, Kallen A, Kim K, Misrahi M, Mousa A, Nappi R, Rocca W, Ruan X, Teede H, Vermeulen N, Vogt E, Vincent A, Yeganeh L, Giri R, Flanagan M. Evidence-based guideline: premature ovarian insufficiency,. Human Reproduction Open 2024, 2024: hoae065. PMID: 39660328, PMCID: PMC11631070, DOI: 10.1093/hropen/hoae065.Peer-Reviewed Original ResearchHealth care professionalsClinical practice guidelinesCentre for Research ExcellencePremature ovarian insufficiencyProvision of careGuideline development groupCare professionalsDiagnosis of premature ovarian insufficiencyAnti-Mullerian hormoneAmerican Society for Reproductive MedicineBritish Menopause SocietyData Safety Monitoring BoardRandomized controlled trialsPractice guidelinesInternational Menopause SocietyHormone therapyScoping surveyBayer PharmaWomen's healthConsulting feesMenopause SocietyReproductive Scientist Development ProgramAdvisory boardOvarian insufficiencyAttending meetingsO-111 Premature ovarian insufficiency: new data and updated guidance
Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, Gravholt C, Kalantaridou S, Kallen A, Kim K, Misrahi M, Nappi R, Rocca W, Ruan X, Teede H, Vermeulen N, Vogt E, Vincent A. O-111 Premature ovarian insufficiency: new data and updated guidance. Human Reproduction 2024, 39: deae108.122. DOI: 10.1093/humrep/deae108.122.Peer-Reviewed Original ResearchPremature ovarian insufficiencyAmerican Society for Reproductive MedicineEvidence-based recommendationsOvarian insufficiencyInternational Menopause SocietyDiagnosis of premature ovarian insufficiencyIatrogenic premature ovarian insufficiencyManagement of premature ovarian insufficiencyClinical questionsNon-hormonal treatmentsHormone therapyFertility preservationTreatment optionsClinical managementMenopause SocietyGuideline groupDevastating conditionEuropean guidelinesHormone treatmentClinical guidanceSexual functionReproductive medicineMusculoskeletal healthMuscle healthWomen's Health